A bibliometric analysis of oncolytic virotherapy combined with immunotherapy

被引：0

作者：

Zhang, Ting ^{[1
]}

Jiang, Shitao ^{[1
]}

Zhang, Lei ^{[1
]}

Liu, Yaoge ^{[1
]}

Zheng, Han ^{[1
]}

Zhao, Haitao ^{[1
]}

Du, Shunda ^{[1
]}

Xu, Yiyao ^{[1
]}

Lu, Xin ^{[1
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Liver Surg, State Key Lab Complex Severe & Rare Dis, 1 Shuaifuyuan, Beijing 100730, Peoples R China

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2024年 / 20卷 / 01期

关键词：

Oncolytic virotherapy; immunotherapy; bibliometrics; VOSviewer; CiteSpace; COMBINATION; CHECKPOINT; NIVOLUMAB;

D O I：

10.1080/21645515.2024.2406621

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Oncolytic virotherapy in combination with immunotherapy has demonstrated significant survival benefits in some types of cancer. Here, we summarized the development, research hotpots and potential trends of the combination therapy using visual bibliometric analysis. A total of 712 articles were retrieved on June 21, 2023. The USA was the top contributors of any country (325, 45.65%), and the Rluk Research Libraries UK ranked first (43, 6.03%) of any institutions. The Journal for ImmunoTherapy of Cancer was with the largest publications (60, 8.43%). 'Tumor microenvironment' and 'delivery' were citation keywords with the strongest ongoing bursts. Research fronts in the future may focus on the methods of virus delivery and tumor microenvironment modulation. Futhermore, the most extensively studied cancer were melanoma, glioma and hepatocellular carcinoma.

引用

页数：8

共 50 条

[1] Combined oncolytic virotherapy and immunotherapy for malignant mesothelioma
Guo, Z. Sheng
Zhou, Jingjiao
O'Malley, Mark E.
Sathaiah, Magesh
Bartlett, David L.
CANCER RESEARCH, 2012, 72
[2] Oncolytic virotherapy as immunotherapy
Melcher, Alan
Harrington, Kevin
Vile, Richard
SCIENCE, 2021, 374 (6573) : 1325 - 1326
[3] Oncolytic Virotherapy Combined With Immunotherapy in Diffuse Intrinsic Pontine Glioma
Osuna Marco, M.
Alcaide Alvarez, C.
Martinez Romera, I.
Ramos Lopez, M.
Alonso Gutierrez, R.
Tejada Solis, S.
Villa Alcazar, M.
Lopez-Ibor Alino, B.
PEDIATRIC BLOOD & CANCER, 2020, 67 : S423 - S424
[4] Immunotherapy: Oncolytic virotherapy enables checkpoint blockade
Crunkhorn S.
Nature Reviews Drug Discovery, 2018, 17 (2) : 96 - 96
[5] Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for Glioma
Tang, Bingtao
Guo, Zong Sheng
Bartlett, David L.
Yan, David Z.
Schane, Claire P.
Thomas, Diana L.
Liu, Jia
McFadden, Grant
Shisler, Joanna L.
Roy, Edward J.
CLINICAL CANCER RESEARCH, 2020, 26 (09) : 2216 - 2230
[6] APPLICATIONS OF MATHEMATICAL MODELLING IN ONCOLYTIC VIROTHERAPY AND IMMUNOTHERAPY
JENNER, A. D. R. I. A. N. N. E. L.
BULLETIN OF THE AUSTRALIAN MATHEMATICAL SOCIETY, 2020, 101 (03) : 522 - 524
[7] Combining oncolytic virotherapy and adoptive immunotherapy for cancer
Kasahara, Noriyuki
JOURNAL OF GENE MEDICINE, 2008, 10 (04): : 440 - 441
[8] Synergistic combination of oncolytic virotherapy and immunotherapy for glioma
Tang, Bingtao
Guo, Zong Sheng
Bartlett, David L.
Yan, David
Schane, Claire P.
Liu, Jia
McFadden, Grant
Shisler, Joanna L.
Roy, Edward J.
CANCER RESEARCH, 2019, 79 (13)
[9] Synergistic combination of oncolytic virotherapy and immunotherapy for glioma
Tang, Bingtao
Guo, Zong Sheng
Bartlett, David
Liu, Jia
McFadden, Grant
Shisler, Joanna
Foss, Kari
Phillips, Heidi
Lichtor, Terence
Roy, Edward
CANCER RESEARCH, 2020, 80 (16)
[10] Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Volovat, Simona Ruxandra
Scripcariu, Dragos Viorel
Vasilache, Ingrid Andrada
Stolniceanu, Cati Raluca
Volovat, Constantin
Augustin, Iolanda Georgiana
Volovat, Cristian Constantin
Ostafe, Madalina-Raluca
Andreea-Voichita, Slevoaca-Grigore
Bejusca-Vieriu, Toni
Lungulescu, Cristian Virgil
Sur, Daniel
Bobac, Diana
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)

← 1 2 3 4 5 →